Skip to content
‹ Back to IndustriesHealthcare

The Art of Waiting: Making COVID-19 Vaccine Rollouts More Efficient and Cutting Wait Times

The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies. It’s tough to consume news coverage and not see scenes of long lines of cars or people…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
The Art of Waiting: Making COVID-19 Vaccine Rollouts More Efficient and Cutting Wait Times

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies.

It’s tough to consume news coverage and not see scenes of long lines of cars or people at vaccine rollout sites as counties and states wrestle with the best way to begin protecting people in their communities.

Those lines may be preventable, said Erik Berg, VP of Marketing for NEMO-Q, and it starts with understanding exactly how many people a facility can handle and when they should be asked to join the queue.

“Where we come in is we provide lots of crucial KPIs so these facilities can be as efficient as possible,” Berg said. “Second, when it comes to vaccinating people and getting people tested, 60 seconds adds up to a minute, 60 minutes add up to an hour and so on. We really provide incredibly detailed service times, what you can expect and how long it will take to vaccinate people or test them, so we can get people in and out as quickly and efficiently as possible.”

Providers or government agencies may think their hands are tied by the price of a system like NEMO-Q’s, but the company is working to help stop the spread of COVID-19, as well, and has an affordable and easy-to-use solution for most vaccine providers.

“It is incredibly cost-effective and simple on the end of the healthcare provider,” Berg said. “They’re pretty much hands-off with the process. We know what they need at this point, so we’re looking to be as big of an ally as possible. The budget can stay low. Even some of our more cost-effective, simpler products can make a world of difference when it comes to getting these patients seen as quickly as possible,” Berg said. “We’re willing to work with all these healthcare facilities as best we can.”

With the company’s experience working with healthcare providers even before the pandemic started, solutions required now during the peak of the pandemic can be easily repurposed when the situation improves and things like flu shots, routine appointments, or aches and pains become the primary focus once again. With effective queuing solutions, that could happen even faster than expected.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Zocdoc's first acquisition in nearly 20 years is an insurance checker

Zocdoc's first acquisition in nearly 20 years is an insurance checker

Zocdoc has bought Sohar Health, its first acquisition in nearly 20 years. Sohar's software finds and verifies a patient's insurance coverage from a name and birth date. Zocdoc wants that check to work across its Care Access Network, which lets insurers, consumer apps and AI tools embed Zocdoc's clinician search and scheduling on their own websites and apps.

  • 01After nearly 20 years without an acquisition, Zocdoc's first purchase is the insurance check that sits between a patient's search and a booked appointment.
  • 02For practices that pay Zocdoc per booking, the sharper question is how often coverage verified at booking matches what the front desk confirms at check-in.

Oct 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512